RxDoctor Payments Data

Elizabeth Laroche, MD

Obstetrics & Gynecology · Murfreesboro, TNNPI 1407807761

Payments from drug & device makers

$3,749in general payments, 2019–2025

Across 186 payments — averaging $20.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Amgen$372
  • Astellas Pharma US Inc$260
  • Pfizer$181
  • Currax Pharmaceuticals LLC$166
  • Radius Health, Inc.$164
  • plus $2K from 24 others

What the payments were for

  • Food & beverage$3,736100%
  • Education$130%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,749 in reported general payments places this provider in the 80th percentile of 763 obstetrics & gynecology providers in Tennessee.

See all obstetrics & gynecology providers in Tennessee

Medicare billing

Part B allowed, 2024
$46,571
Medicare patients
347
Services billed
634

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
PremarinEstrogens, Conjugated54$14,951
GemtesaVibegron13$12,818
Estradiol219$7,391
CombipatchEstradiol/Norethindrone Acet16$5,736
ProgesteroneProgesterone, Micronized68$3,477
Arnuity ElliptaFluticasone Furoate12$3,090
Estradiol (Twice Weekly)Estradiol19$1,541
Estradiol (Once Weekly)Estradiol19$1,349
Raloxifene Hcl13$1,208
Ventolin HfaAlbuterol Sulfate20$1,051
Bupropion XlBupropion Hcl32$1,025
Clobetasol Propionate12$917
ValacyclovirValacyclovir Hcl17$894
Oxybutynin Chloride ErOxybutynin Chloride36$558
Ibandronate Sodium16$509

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerPremarin$181$14,95154 claims
Sumitomo Pharma America, Inc.Gemtesa$124$12,81813 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 763 obstetrics & gynecology providers in Tennessee.

Other obstetrics & gynecology in Murfreesboro

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →